Slide presentations

Displaying 1 - 424 of 424
Aspergillosis in wild and captive birds in Japan T. Yanai ISHAM Tokyo May 25-29 2009
Research priorities in Medical Mycology DW. Denning ECCMID 22nd (2012), London, UK
Role of (1-3)-beta-D-glucan in the diagnosis of Invasive Aspergillosis F. Marty Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The discovery of new, orally-active inhibitors of ß-1,3-glucan synthesis as anti-fungal agents Mike Peel, PhD Antifungal Drug Development Summit
ABPA in Cystic Fibrosis: How is it Different from ABPA in Asthma? Richard Moss ISHAM 2015
Risk assessment in the hemato-onco patient Markus Ruhnke Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Toll-like receptors: recent advances, open questions and implications for aspergillosis control F. Ebel Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Managing chronic pulmonary aspergillosis- Recent results with Voriconazole J. Cadranel European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
New taxa in the Aspergillus genus J. Varga et al Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Aspergillosis - who gets what, why and when? DW. Denning Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
CLSI update Mahmoud Channoum Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Aspergillus infection in patients supported on extracorporeal membrane oxygenation (ECMO). Isabel Rodriguez Goncer ECCMID 27th (2017) Vienna , Austria
Aspergillus sinusitis in paediatric case with AML (with videos) R. Migliavacca Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Fungal Biomarkers in Transplantation Hanson Kimberley ICAAC 2014, Washington Sep 5-9
Invasive aspergillosis in critically Ill patients. A new 21th century problem? K. Vandewoude Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Difference in invasive aspergillosis in solid organ transplant recipients S. Husain Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Management of chronic pulmonary aspergillosis K. Izumikawa Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
New immunosuppressive agents as risk factors for fungal infections G. Maschmeyer Trends In Medical Mycology 3rd (TIMM)
Pharmacodynamics of F901318 against Aspergillus fumigatus in a rabbit model of invasive pulmonary aspergillosis (IPA) William Hope ECCMID 27th (2017) Vienna , Austria
Genetic susceptibility to Aspergillosis in allogeneic stem cell transplantation A. Carvalho Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Cystic fibrosis and moulds Giraud, Symoens & Bouchara ISHAM 2015
Infection in the cystic fibrosis lung Dr. Stuart Elborn HS Talks
Management of invasive aspergillosis DW. Denning Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Treatment of infections by crypic Aspergillus species Alessandro C. Pasqualotto Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillus sinusitis DW. Denning ISHAM 2006 June 25-29, Paris 2006
Radiology of pulmonary invasive fungal infections DL. Escuissato Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Metabolic fingerprinting as a diagnostic tool for invasive aspergillosis: a pilot study Maria Siopi ECCMID 27th (2017) Vienna , Austria
Advances in the diagnosis of invasive Aspergillosis P. Verweij Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Designing new diagnostic-driven therapy concepts Johan Maertens ECCMID 24th (2014), Barcelona, Spain
Hospital water and invasive fungal infection P. Gaustad ECCMID 18th (2008) Barcelona, Spain.
Invasive Aspergillosis in India: Unique Challenges R. Soman Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Regulation of immunity in bronchiectasis and ABPA R. Boyton Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
New Antifungal Drugs in the Pipeline Prof. Sevtap Arikan-Akdagli, MD ECCMID 25th (2015) Copenhagen Denmark
Aspergillus and aspergillosis: From the environment to the patient J. Guinea ECCMID 20th (2010) Vienna, Austria
Mycopia: Fungal Allies & Fungal Adversaries Sarah Gurr ISHAM 2015
Global epidemiology on fungal infections: The burden of diseases Sevtap Arikan ECCMID 23rd (2013), Berlin, Germany
Invasive aspergillosis : Update on conventional diagnosis J. Bille Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
New agents for aspergillosis: Development pathways and economic pull John H. Rex Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Dynamics of dsRNA mycoviruses in black Aspergillus populations A. Diepeningen Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
New developments and challenges in diagnostics of invasive fungal infections? O. Marchetti Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
News from EUCAST Maiken Cavling Arendrup Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Retrospective observational cohort study comparing the management and outcome of culture-positive invasive aspergillosis due to Aspergillus fumigatus with wildtype and non-wildtype triazole susceptibility Bram Lestrade ECCMID 27th (2017) Vienna , Austria
Factors influencing the Aspergillus fumigatus survival into the host, mediated by the calcineurin pathway. G. Goldman ISHAM Tokyo May 25-29 2009
The Fungal Kingdom - diverse and essential roles in earth's ecosystem (A REPORT FROM THE AMERICAN ACADEMY OF MICROBIOLOGY) M. Buckley General
Case presentation on CPA - Patient AV David Denning General
Fungal Outbreaks Dr. Shawn Lockhart and Dr. Patricia Muñoz ECCMID 25th (2015) Copenhagen Denmark
Managing drug interactions in the patient with aspergillosis RE. Lewis Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Controversies surrounding categorization of fungal sinusitis A. Chakrabarti Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Emerging clinical associations with aspergillosis: COPD and aspergillosis J. Guinea Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
New immunomodulators and invasive fungal infections JH. Young & DP. Kontoyiannis ICAAC 47th Chicago September 17-20th 2007
Targeted imaging of invasive aspergillosis Christopher Thornton ECCMID 27th (2017) Vienna , Austria
Role of azole concentration monitoring (TDM) in patient management Eliane Billaud Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Revolution/Evolution - DNA Sequencing To Identify Indoor Air Microorganisms Jordan Peccia Indoor Air 2015
MLST versus Microsatellites C. Klaassen Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Pulmonary aspergillosis: pathogenesis and treatment DW. Denning International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
Detecting and defining resistance P. Verweij ICAAC 47th Chicago September 17-20th 2007
Aspergillosis in AIDS DW. Denning Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Main Principles for Bioaerosol Sampling and Analysis Tiina Reponen Indoor Air 2015
Multi-modal imaging and non-invasive detection of Aspergillus infection in a rat model Anton Skriba ECCMID 27th (2017) Vienna , Austria
Chronic pulmonary aspergillosis (CPA) in association with tuberculosis and AIDS I. Page Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Salvage therapy of invasive aspergillosis refractory to primary therapy with voriconazole Johan Maertens ECCMID 24th (2014), Barcelona, Spain
Conventional or molecular measurement of Aspergillus load K. Clemons Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Global status of azole resistance in Europe and Asia S. Arikan-Akdagli Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
What do we know about the role of gliotoxin in pathobiology of Aspergillus J. Kwong-Chung Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Aspergillosis - the role of the fungus Paul Eduard Verweij ECCMID 27th (2017) Vienna , Austria
NADPH oxidase: regulator of host defense and inflammation (CGD) B. Segal Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Isavuconazole: spectrum of activity George Thompson ISHAM 2015
Prevention of Fungal Infections: What is the Evidence for Antifungals? S Husain ICAAC, 53rd, Denver September 10-13 2013
Latest developments in the treament of invasive aspergillosis W. Steinbach Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Diagnostic methods to detect Aspergillus species in clinical samples using conventional and non-culture techniques Jesús Guinea Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillosis: New risk groups MC. Arendrup ICAAC 2006 Sept 27-30, San Francisco
Educational resources on the internet M. Richardson & P. Donnelly Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Filamentous fungal infections and the role of amphotericin B DW. Denning ISHAM Tokyo May 25-29 2009
Pneumonia in a presumed immunocompetent patient M Bruyneel and D Konopnicki Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Cryptococcus neoformans copper homeostasis machinery: Therapeutic target in fungal pathogenesis Dennis Thiele, PhD Antifungal Drug Development Summit
Pharmacologic Principles andClinical Evidence forthe Managementof IFDs and Mucormycosis Michelle Ananda-Rajah ISHAM 2015
Risk assessment in the ICU patient Sergio Ruiz-Santana Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Invasive aspergillosis: Elucidation of genetic risk factors for disease A. Zaas Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillosis of the dog and cat R. Kano ISHAM Tokyo May 25-29 2009
Direct detection of resistance in clinical specimens C. Klaassen ECCMID 22nd (2012), London, UK
Interactive case studies: improving clinical outcomes on invasive aspergillosis N. Singh Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Targeting a novel phosphorylated domain in calcineuri Bill Steinbach, MD Antifungal Drug Development Summit
Aspergillus resistance Don Sheppard ISHAM 2015
The antifungal landscape: looking forward John Rex Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Whole genome comparison of A. fumigatus group J. Wortman Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Infection control measures for cancer patients undergoing treatment: prevention of fungal infections in neutropenic patients P. Gastmeier ECCMID 21st / 27th ICC (2011) Milan, Italy
Aspergillus DNA barcoding –progress so far J. Varga et al Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Imaging findings in neutropenic vs. non- neutropenic patients C. Heussel Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
QC of fungi Paul E Verweij MD Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Effective antimicrobial activity of HICA and alpha-mangostin against the multi-species bacterial-fungal biofilms. Warat Leelapornpisid ECCMID 27th (2017) Vienna , Austria
Antifungal Pharmacodynamics - A strategy to Optimize Efficacy D. Andes Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Fungal Infections in the era of Immunobiologicals: Good, the bad and the ugly Baddley John ICAAC 2014, Washington Sep 5-9
Aspergillus fumigatus - Growth and virulence J. Rhodes Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Invasive aspergillosis in steroid-treated patients D. Kontoyiannis Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Regulation of cellular morphogenesis during development in Aspergillus nidulans SD. Harris Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Molecular diagnostics beyond PCR M. Sanguinetti Trends In Medical Mycology 3rd (TIMM)
Metagenomic analysis in routine practice Robert Schlaberg ECCMID 27th (2017) Vienna , Austria
Newer combination therapies W. Steinbach Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Filamentous fungi MALDI-TOF identification Stéphane Ranque ISHAM 2015
Innate-like B cells Prof. John F. Kearney HS Talks
What beneficial role may the laboratory play involving aspergillosis - isolation, identification, serologic diagnoses, susceptibility testing, epidemiology? D. Kontoyiannis Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Aspergillus Speciation in the 21st Century - Implications for Laboratory and Clinical Practice Manuel Cuenca-Estrella Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Avian aspergillosis J. Guillot ISHAM 2006 June 25-29, Paris 2006
Galactomannan testing: lessons from the last decade C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
T-Cells in Aspergillosis - Clinical Aspects Thomas Lehrnbecher ECCMID 24th (2014), Barcelona, Spain
Can we rely on imaging and biomarkers for pre-emptive antifungal therapy in hematological patients? C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
How to define response in clinical trials? B. Pauw ECCMID 18th (2008) Barcelona, Spain.
Pro Management Guidelines of Invasive Fungal Infections OA. Cornely Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Asthma and its phenotypes S. Wenzel Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Targeting Ras-like proteins: a novel approach for antifungal therapy Andy Alspaugh, MD Antifungal Drug Development Summit
Clinical impact of the Blood levels of azoles O. Marchetti ECCMID 20th (2010) Vienna, Austria
Can we agree on grading? Oliver Cornely ISHAM 2015
New generation sequencing any use? Stephane Bretagne Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
History of Medical Mycology in Germany M. Ruhnke Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Culture and sensitisation in asthma, CF and COPD – what does it tell us? Catherine Pashley Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Diagnosis and management of fungal allergy A. Knutsen ICAAC 50th Boston 12th-15th September, 2010
Ochratoxin A in profiling and speciation FJ. Cabanes Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
PCR-where have we gone? M. Cuenca-Estrella Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Commercial tests Joseph Meletiadis PhD Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Prevalence and characterization of azole-resistant Aspergillus fumigatus in German CF-patients Raphael Seufert ECCMID 27th (2017) Vienna , Austria
Transcription profiling of A fumigatus laeA in the murine lung W. Nierman ISHAM Tokyo May 25-29 2009
Fungal keratitis in man A. Tullo General
Rational use of antibiotics: Echinocandins & Lipid formulation of amphotericin B Felipe F Tuon MD, PhD Infocus 2014
AFRS: Current approaches to postoperative management B. Marple Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Chitin synthases of aspergilli: functions of tip growth and morphogenesis in aspergillus nidulans H. Horiuchi Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Update on biologicals for ABPA and asthma RB. Moss Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Design of clinical trials for treatment of invasive fungal infections J. Powers Trends In Medical Mycology 3rd (TIMM)
Innate and adaptive immune defects in chronic pulmonary aspergillosis Felix Bongomin ECCMID 27th (2017) Vienna , Austria
Primary diagnostic approaches - molecular testing S. Bretagne Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Molecular Tools & Microbial Ecology of Buildings - A Practitioner's View Miia Pitkäranta Indoor Air 2015
Multi-locus variable number tandem repeat analysis (MLVA) of clinical and environmental isolates of Aspergillus fumigatus during major deconstruction work in a French hospital Sophie Loeffert ECCMID 27th (2017) Vienna , Austria
The evolution of Aspergillus species D. Geiser Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
The species concept in Aspergillus: recommendations of an international workshop R. Samson Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
CPA new treatment evidence and emergence of azole resisitant A. fumigatus in Japan K. Izumikawa International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
Antifungal drugs in neonates and children W. Steinbach ICAAC 47th Chicago September 17-20th 2007
Amphotericin- or echinocandin-based antifungal prophylaxis approaches J. Young Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Microbial Sampling in Building Surveys - What and Why are We Sampling Maria Nunez Indoor Air 2015
Optimal cut-offs for Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA) in Europe Iain Page ECCMID 27th (2017) Vienna , Austria
Paediatric aspergillosis: New findings and unique aspects W. Steinbach Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
First-line therapy with combined antifungal for aspergillosis Raoul Herbrecht ECCMID 24th (2014), Barcelona, Spain
Proteome analysis for pathogenicity and new diagnostic markers O. Kniemeyer Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Top 3 Papers in Aspergillosis for Clinical Sciences M. Akova Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Subtelomeric diversity as a major force in evolution of Aspergillus secondary metabolism and virulence pathways B. Nierman Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Aspergillosis - the role of the host Carolina Garcia Vidal ECCMID 27th (2017) Vienna , Austria
Azole resistance in Aspergillus– is it a problem? S. Howard Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Global burden of fungal diseases David Denning ISHAM 2015
ICAAC 2013 Top 10 Papers in Mycology T. Patterson ICAAC, 53rd, Denver September 10-13 2013
The importance of early appropriate therapy of invasive aspergillosis H. Boucher Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Clinical profile of cryptic Aspergillus species David W. Denning Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Five talks - powerpoint slides and audio presentations (NYAS members only) DW. Denning; K. Marr; T. Walsh; JP. Latge; G. Brown New York Academy of Sciences: Invasive aspergillosis - New approaches against a dangerous fungal infection
The association between environment and fungal disease M. Richardson Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Fungal infections in non-neutropenic patients - CPA K. Izumikawa ISHAM Tokyo May 25-29 2009
Invasive Aspergillosis in Allogeneic stem cell transplantation (ASID 2005) K. Singh General
Discovering molecules to probe and treat malaria Emily Derbyshire, PhD Antifungal Drug Development Summit
Aspergillus PCR achieving standardisation Peter Donnelly
Direct detection of resistance :candins vs azoles David Perlin Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
PCR -platforms strengths and weaknesses L. White Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Identification and characterization of novel antifungal small molecules Damian Krysan, MD, PhD Antifungal Drug Development Summit
Aspergillosis in Companion Animals - fungal rhinosinusitis Vanessa Barrs ISHAM 2015
Fungal Biomarkers B Sendid & O Marchetti Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
What's new in the Aspergillus niger genome? S. Baker Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Prophylaxis limitations: Challenges in the management of invasive aspergillosis P. Chandrasekar Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Application of PK/PD concepts and the role of TDM in the management of patients with fungal disease. The role of combination therapy as of May 2011 C. Viscoli ECCMID 21st / 27th ICC (2011) Milan, Italy
Biodiversity of aspergillus sp. nigri from grapes in Europe G. Perrone Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Epidemiology and surveillance of fungal infections: an overview D. Warnock Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
ECMM external quality control programs in mycology Dr Elizabeth Johnson, Dr Paul Verweij Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Clinical/bedside/treatment: Top ten papers Carolina Garcia Vidal ECCMID 27th (2017) Vienna , Austria
Diagnosis of Fungemia using Molecular Methods A. Salles Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Top 10 Mycology papers Patterson T and Konoyiannis D (presenters) and many others ICAAC 2014, Washington Sep 5-9
Global control of Aspergillus fumigatus toxins N. Keller Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs T. Hohl Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Controversies in management: prophylaxis or diagnostics. Caveats in the use of biological markers for early diagnosis DE. Karageorgopoulos Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Fungal infections in cystic fibrosis E. Castagnola Trends In Medical Mycology 3rd (TIMM)
A chance for treatment - immunotherapy in the prevention and treatment of chronic fungal infections Frank van de Veerdonk ECCMID 27th (2017) Vienna , Austria
TB and the rising tide of chronic pulmonary aspergillosis DW. Denning Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
What Can We Learn From Immunodeficiency Syndromes About Treating IFI Michail Lionakis ISHAM 2015
Aspergillosis infections and the lung Prof. Rosemary Barnes HS Talks
Treatment of invasive mycoses in the European Community: Contrasts and comparisons with American clinical practice P. Verweij Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Epidemiology of infections by cryptic species of Aspergillus Jan W.M. van der Linden Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Filamentous fungi and chronic respiratory infections in cystic fibrosis JP. Bouchara ISHAM 2006 June 25-29, Paris 2006
Classical Mycology - We still need the basics P. Godoy Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Pharmacokinetics of antifungal agents in pediatric patients A. Groll ISHAM Tokyo May 25-29 2009
Maldi-Tof in the clinical route M. Sanguinetti ECCMID 22nd (2012), London, UK
Monitoring antifungal treatment response in neutropenic patient with aspergillosis CA. Cunha Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
The role of fungi in respiratory allergies DW. Denning British Mycological Society, 6-8 April 2009 (BMS)
Treatment of invasive aspergillosis DW. Denning Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Differences in the immunobiology of Aspergillus colonization and ABPA J. Kolls Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
History and chemical diversity of the echinocandin lipopeptide antifungal metabolites Gerald Bills, PhD Antifungal Drug Development Summit
Antifungal susceptibility testing. Which method and when? JL. Rodriguez-Tudela ECCMID 20th (2010) Vienna, Austria
Pharmacokinetic and pharmacodynamic considerations for pediatric antifungal dosing William Hope ISHAM 2015
The global fungal burden David Denning Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Update on antigen detection P. Verweij Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Targetting Aspergillus fumigatus virulence factors in a mouse model of corneal infection E. Pearlman Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
The spectrum of aspergillosis DW. Denning European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Experience from the yeast database V. Robert Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
In vitro cross-resistance between azoles in Aspergillus fumigatus: a reason for concern in the clinic? E. Mellado Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
How do I treat Invasive Fungal Infections? Aspergillosis Andrew J. Ullmann, M.D. Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Comparison of two molecular assays concerning detection and characterization of Aspergillus fumigatus azole resistance and cyp51A mutations in clinical isolates and primary clinical samples of immunocompromised patients Birgit Spiess ECCMID 27th (2017) Vienna , Austria
Differential diagnosis of rhinosinusitis H. Saleh British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)
The extraordinary spectrum of diseases caused by Aspergillus DW. Denning General
Antifungal Antimicrobial Stewardship: Reduced Costs and Improved Care. Rational Use of Triazoles Vivian M. Carvalho Hessel Dias Infocus 2014
Allergen genomics P. Bowyer Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Sexual structures in Aspergillus- morphology importance and genomics D. Geiser Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Pre-emptive vs. empirical treatment O. Uzun Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Combination antifungal therapy J. Edwards Trends In Medical Mycology 3rd (TIMM)
Antifungal prophylaxis in AML patients receiving intensive induction chemotherapy. A prospective observational study from the Acute Leukemia French Association (ALFA) group Mauricette Michallet ECCMID 27th (2017) Vienna , Austria
Fungal airway infection and proteinase-dependent atopy and asthma: an emerging paradigm D. Corry Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Indoor molds and fungal rhinosinusites; Can we improve detection of fungi from the sinuses? Valentina Arsić Arsenijević Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Antimicrobial susceptibility testing with EUCAST breakpoints and methods Maiken Cavling Arendrup ECCMID 27th (2017) Vienna , Austria
Microtubules and polarized growth in Aspergillus nidulans R. Fischer Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
Fighting against fungal infections: cells on the front lines Emmanuel Roilides ECCMID 24th (2014), Barcelona, Spain
Treatment guidelines for invasive aspergillosis T. Patterson ICAAC 47th Chicago September 17-20th 2007
Optimal Prophylaxis: Case for Fluconazole/ Itraconazole P.H. Chandrasekar Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Microbila Growth and Interactions on Indoor Surfaces - Microbila Secondary Metabolites and Mycotoxins Kristian F. Nielsen Indoor Air 2015
Analysis of genes regulating the production of the invasive aspergillosis biomarker bis (methylthio) gliotoxin within genus Aspergillus and other opportunistic fungi Matxalen Vidal-García ECCMID 27th (2017) Vienna , Austria
Microscopic Observation and culture of Aspergillus species: The traditional way N. McClenny Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Therapeutic monitoring of drug levels for invasive aspergillosis Susan Howard ECCMID 24th (2014), Barcelona, Spain
Immune reconstitution syndrome in immunosuppressed hosts with opportunistic infections N. Singh ECCMID 18th (2008) Barcelona, Spain.
Is pre-emptive therapy a realistic approach? JP. Donnelly Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Aspergillus and biotechnology S. Baker Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Non-neutropenic patients and aspergillosis David A. Stevens ECCMID 27th (2017) Vienna , Austria
Alternative models for studying Aspergilli P. Warn Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Controlling cereal diseases: progress and challenges Robert Park ISHAM 2015
Can statins be useful in invasive fungal infections? P Bergman ECCMID 23rd (2013), Berlin, Germany
The use of RNAi to suppress gene function in industrial fungi NS. Dunn-Coleman British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
Multi-resistant aspergillosis due to cryptic species Susan Howard Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
het-genes in Aspergillus niger K. Pal Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Intrapulmonary drug distribution & pharmacodynamic interactions of antifungal drugs with host cells RE. Lewis Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Resistance mechanisms to antifungals David Perlin ECCMID 27th (2017) Vienna , Austria
Animal models in preclinical trials of aspergillosis K. Clemons ISHAM Tokyo May 25-29 2009
Lipid Amphotericin B formulations and Echinocandins R. Lewis General
A Novel Arylamidine Antifungal Drug, T-2307 Yoshiko Fukuda, PhD Antifungal Drug Development Summit
Aspergillus galactomannan & PCR in perspective for haematology patients Dr. Orla Morrissey ISHAM 2015
Which antifungal for which site of infection? David Andes Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Status of susceptibility testing in Aspergillus C. Lass-Flörl Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Antifungal treatment of severe asthma DW. Denning Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
A. oryzae is good at usage of hydrolysing enzyme on solid surfaces Abe & Takahashi International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
Antifungal drug use in children: a regulatory perspective Brian Fisher ISHAM 2015
Paediatric mycoses: treatment and prophylaxis Andreas Groll Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Whole genome comparison of A. flavus and A. oryzae G. Payne Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Host response signatures to invasive aspergillosis T. Zelante Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Invasive fungal infections in our hospitals today O. Lortholary ECCMID 21st / 27th ICC (2011) Milan, Italy
Mating type and species recognition in the aspergilli P. Dyer Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Surgical treatment: for whom and when? G. Massard Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Sloan Symposium Conference Workshop Indoor Air 2015
Top papers in diagnostics/laboratory Michaela Lackner ECCMID 27th (2017) Vienna , Austria
Discussion and analysis of the major trials in invasive aspergillosis DW. Denning Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Agricultural triazole fungicides should be withdrawn K. Lagrou Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Infection Risk Modeling in Solid Organ Transplantation: The Fungal Problems Shahid Husain ICAAC 2014, Washington Sep 5-9
Infections in non-myeloablative « Reduced intensity conditioning » stem cell transplant C. Cordonnier ECCMID 16th (2006) Nice, France
Stage-specific Innate Immune Recognition of Aspergillus fumigatus and Modulation by Echinocandin Drugs T. Hohl Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis R. Ben-Ami Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Fungal infections in COPD W. Meersseman Trends In Medical Mycology 3rd (TIMM)
What can we learn from the EORTC and what can we do together? J. Peter Donnelly ECCMID 27th (2017) Vienna , Austria
Invasive aspergillosis in acute leukaemias M. Caira Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Environmental Epidemiology and Prevention of Mould Infection Jan Patterson ISHAM 2015
Assessment of the Biodegradability of Containers for Low- and Intermediate-Level Nuclear Waste Borys Zlobenko Second Research Coordination Meeting of IAEA CRP:Behaviour of Cementitious Materials in Long Term Storage and Disposal of Radioactive Waste IAEA Research
The hodge-podge of azole antimyotics: Prudent choices and uses J. Perfect Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
In vivo response in a mixed infection model of azole susceptible and resistant Aspergillus spp. strains Laura Alcazar-Fuoli Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Galactomannan - Role in pre-emptive therapy J. Maertens ICAAC 2006 Sept 27-30, San Francisco
Prevention of invasive fungal infections in solid organ transplant recipients: Universal or Targeted Prophylaxis? P. Grossi Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Antifungal therapy for children A. Groll ISHAM Tokyo May 25-29 2009
Invasive aspergillosis in the ICU D. Vogelaers Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Antifungal drug combinations Gerry Wright, PhD Antifungal Drug Development Summit
Invasive aspergillosis in patients taking steroids A. Pasqualotto Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Sick building syndrome B. Crook British Mycological Society, 6-8 April 2009 (BMS)
Medical Mycology in India: Past, Present & Future (Presidential address) A. Chakrabarti Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Cerebral aspergillosis: Tissue penetration is the key S. Schwartz Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Discovery of natural products that potentiate the activity of current antifungal drugs Ameeta Agarwal, PhD Antifungal Drug Development Summit
Aspergillus resistance mechanisms, susceptibility testing and breakpoints M. Arendrup ECCMID 20th (2010) Vienna, Austria
MYCAFRICA - A network to promote Medical Mycology in Africa Mushi, Grob et al ISHAM 2015
Role of non culture biomarkers for detection of fungal infections Tom Rogers Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Fungal infections in cancer patients G. Maschmeyer Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
CT imaging in Aspergillus lung infections CP. Heussel European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Genetic diversity in A. flavus (S & L) K. Ehrlich Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Prophylaxis, empirical, pre-emptive therapy of aspergillosis in hematological patients: which strategy? G. Maschmeyer Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Allergic and chronic aspergillosis: lessons for the busy mycologist: Sinusitis Helen Sambatakou Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Unveiling the mechanistic basis underlying Aspergillus fumigatus 5-flucytosine resistance Fabio Gsaller ECCMID 27th (2017) Vienna , Austria
Concepts in rhinosinusitis N. Jones British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)
An introduction to fungi and Aspergillus in health and disease Jenny Bartholomew General
Integration of host genomics into infectious risk in AML patients: challenges and opportunities Samuel Shelburne ICAAC 2014, Washington Sep 5-9
Aspergillosis in the USA, UK and Japan in 20th Century DW. Denning Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Diagnostic imaging in experimental invasive pulmonary aspergillosis T. Walsh Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Top 3 Basic Science Papers on Aspergillus fumigatus 2011 N. Osherov Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Aspergillus in the non-neutropenic host J. Garbino Trends In Medical Mycology 3rd (TIMM)
Audit of voriconazole therapeutic drug monitoring in an English hospital after the implementation of electronic prescribing (EPIC) David Enoch ECCMID 27th (2017) Vienna , Austria
Detection of fungal infections with radiolabelled antifungal agents A. Lupetti Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Indoor fungal exposure and disease Malcolm Richardson PhD, FRSB, FISSE, FRCPath Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Influence of eicosanoid lipid mediators on macrophage innate immune functions Prof. Marc Peters-Golden HS Talks
The comparative genomics of Aspergilli W. Nierman Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
Visual session of unusual Aspergillus species: images and plates J. Varga, S. Kocsubé, G. Szigeti, N. Baranyi, J. Houbraken, R. A. Samson Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Epidemiology and outcomes of IA in the 21st Century: Strengths and weaknesses of surveillance databases D. Neofytos Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Assessment of Moisture and Mold Problems - the Finnish Example Anne Hyvärinen Indoor Air 2015
Detection of clinically relevant cryptic Terrei species using AspID Multiplex qPCR kit Gemma Johnson ECCMID 27th (2017) Vienna , Austria
Chronic pulmonary aspergillosis DW. Denning Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Persistent febrile neutropenia: diagnostic-driven antifungal therapy vs. empirical antifungal therapy Manuela Aguilar-Guisado ECCMID 24th (2014), Barcelona, Spain
Management of confirmed aspergillosis O. Cornely ECCMID 18th (2008) Barcelona, Spain.
Visualising phagosomal killing of Aspergillus fumigatus JM. Vyas Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Clinical trial design for mould–active agents: Time to break the mold E. Anaissie Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
In-vitro activity of F901318 and comparators against clinical isolates of cryptic species of Aspergillus Ana Alastruey-Izquierdo ECCMID 27th (2017) Vienna , Austria
Aspergillus: nosocomial or community acquired? P. Vanhems Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Neglected fungal infections of eye Ariya Chindamporn ISHAM 2015
Antifungal dosing and therapeutic drug monitoring A Ullmann ECCMID 23rd (2013), Berlin, Germany
Genome and proteomic analysis of industrial fungi SE. Baker British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
Study of antifungal resistance mechanisms in cryptic species Emilia Mellado Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Species delimitation in Aspergillus section fumigatus based on polyphasic taxonomy SB. Hong Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Invasive mycoses in cystic fibrosis and lung transplant E. Castagnola Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
A bird's eye view of the fungal kingdom - a quest for nomenclature stability (1) Sybren de Hoog Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vsstandard-of-care following initial intravenous echinocandin therapy in the treatment of.. Peter G. Pappas ECCMID 27th (2017) Vienna , Austria
Should we monitor plasma levels of antifungal agents? D. Andes ISHAM Tokyo May 25-29 2009
An introduction to anti-fungal pharmacology R. Lewis General
New antifungal development: What are the needs and do we have the answers? John Perfect MD Antifungal Drug Development Summit
Fungi, fungal infections and immunity in the metagenomic era Luigina Romani ISHAM 2015
Antifungal PK/PD made simple David Andes Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Critique of trials in ABPA and fungal allergy R. Moss Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Allergic fungal sinusitis M. Schubert Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Management of Aflatoxigenic Fungi in Groundnut Varieties in Central Tigray through Soil Solarization and Planting Time T. Kahsat et. al. Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Epidemiology of invasive fungal infections in children T. Zaoutis ICAAC 47th Chicago September 17-20th 2007
Non-fumigatus Aspergilli Fungi that catch you out -Diagnostics and management John W. Baddley ISHAM 2015
Solid organ transplant patients Jose Aguado Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Airborne fungal fragments and allergenicity B. Green Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Cultivated anti-Aspergillus TH1 Cells T. Lehrnbecher Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Non culture based diagnosis of aspergillosis C. Lass-Flörl ECCMID 21st / 27th ICC (2011) Milan, Italy
The importance of aspergilli in biotechnology P. Dijck Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Primary immunodeficiencies and fungal infections A. Warris Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Optical Particle Recogntion for (Practical) Discrimination Between Bioaerosol Classes Mark Hernandez Indoor Air 2015
Fungal endocarditis Mario Venditti ECCMID 27th (2017) Vienna , Austria
First line therapy for IA C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Fungal-Specific Mechanisms of Ras-Mediated Morphogenetic Signaling in Aspergillus fumigatus J. Fontwendel Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Modeling to Assess Antifungal Treatment Strategies in High Risk Patients: Haematological Malignancies Russell Lewis ICAAC 2014, Washington Sep 5-9
Postoperative aspergillosis AC. Pasqualotto ECCMID 16th (2006) Nice, France
Granulocyte products act as alarmins to enhance innate and adaptive immunity D. Yang Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Update on resistance mechanisms: Highly active triazole antifungal agents DS. Perlin Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Interaction of Aspergillus with human respiratory mucosa R. Amitani Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
New cancer treatments - what the ID specialist needs to know Livio Pagano ECCMID 27th (2017) Vienna , Austria
Aspergillosis in transplant patients F. Saliba Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
FUNGAL VIRULENCE FACTORS IN OCULAR INFECTIONS Philip Thomas General
Breakpoints and epidemiological cutoff values (BPs and ECVs): Can they predict clinical response? Ana Espinel-Ingroff, MS,PHD ISHAM 2015
Combination anti-fungal therapy: current concepts, lab investigations and clinical trials T. Walsh Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Current classification of the clinically relevant Aspergillus species complexes Cornelia Lass-Flörl Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Chronic pulmonary aspergillosis DW. Denning ICAAC 2006 Sept 27-30, San Francisco
Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection (IFI) in allogeneic hematopoietic cell transplant (HCT) recipients D. Marks Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Are fungi responsible for chronic sinusitis? A. Chakrabarti ISHAM Tokyo May 25-29 2009
Aspergillosis spectrum of disease DW. Denning Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Chemical genomics-based antifungal drug discovery Terry Roemer PhD Antifungal Drug Development Summit
Aspergillosis in breeding turkeys J. Guillot ISHAM Tokyo May 25-29 2009
How to best diagnose fungal infections Lass-Flörl ECCMID 22nd (2012), London, UK
Sick building syndrome: Is mould the cause? A. Terr Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The fungal Achilles Heel: Targeting Hsp90 to cripple fungal pathogens Leah Cowen, PhD Antifungal Drug Development Summit
Epidemiology, Prevention and Diagnosis of fungal infections in solid organ transplant Husain Shahid ISHAM 2015
The role of lymphocytes & IFD in the transplant setting Andrew Ullman Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Update on glucan detection M. Richardson Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Diagnostic advances for distinct patient populations JP. Gangneux European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Aflatoxin biosynthesis and regulation K. Ehrlich Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Therapeutic drug monitoring in antifungal therapy,why, when and how? R. Brüggemann Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) Dr Ritesh Agarwal MD, DM Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Invasive fungal disease in paediatric patients undergoing therapy for a haematological malignancy or receiving allogeneic haematopoietic stem-cell transplantation: an interim analysis of the prospective multicentre study IFI-PED Thomas Lehrnbecher ECCMID 27th (2017) Vienna , Austria
Is azole resistance increasing amongst Aspergillus species? C. Lass-Florl Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Transplant recipients with fungal infections: How do we effectively use the clinical microbiology lab Hanson Kimberley ICAAC 2014, Washington Sep 5-9
ABPA and asthma fungal sensitisation A. Knutsen Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillosis - Invasive disease in patients with leukemia J. Maertens Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Neutrophil granulocytes in their defence against invasive aspergillosis M. Gunzer Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Invasive mycoses in the brain L. Pagano Trends In Medical Mycology 3rd (TIMM)
Management and outcome of culture-positive invasive aspergillosis in an area with high prevalence of voriconazole resistance Robbert Bentvelsen ECCMID 27th (2017) Vienna , Austria
Aspergillus Endocarditis J. McCormack Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Burden of invasive fungal infections in developing countries Arunaloke Chakrabarti Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
O-GlcNAc, an essential regulator of numerous cellular pathways Dr. Natasha Zachara HS Talks
Management of allergic aspergillosis D. Stevens Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Diagnosis and treatment of invasive aspergillosis — Are we doing it well? Patricia Muñoz Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Diagnosis of pulmonary aspergillosis DW. Denning ISHAM 2006 June 25-29, Paris 2006
What are we looking at? Challenges in the diagnosis of invasive mould diseases A. Pasqualotto Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Moisture and the Indoor Microbiome Jeffrey Siegel Indoor Air 2015
Cause of death in the ICU - autopsy findings Alexander Wilmer ECCMID 27th (2017) Vienna , Austria
What the Aspergillus genomes have told us W. Nierman Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Innate immunity and infections in transplant patients - new insights José M. Aguado ECCMID 24th (2014), Barcelona, Spain
Evolving invasive fungal infections - What are the reasons and implications for the change D. Kontoyiannis ECCMID 18th (2008) Barcelona, Spain.
Epidemiology of Fungal Endophthalmitis N. Nayak Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Mechanisms behind the CF-ABPA link D. Harti Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Do animal models help predict host responses to fungal infections and antifungal treatment? J. Adler-Moore ECCMID 20th (2010) Vienna, Austria
Current rates of resistance, impact on clinical use and prescribing of drugs Manuel Cuenca Estrella ISHAM 2015
Fungal epidemiology in CF patients & overview of EUCAST breakpoints C Laas-Florl ECCMID 23rd (2013), Berlin, Germany
What can genomics tell us about secondary metabolism in Aspergillus G. Turner British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
In vitro antifungal susceptibility of cryptic Aspergillus species Ana Alastruey Izquierdo Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Genome sequencing and analysis of the versatile cell factory Aspergillus niger N. Peij Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Fungal infections in COPD W. Meersseman Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Emerging fungal threats to animal plant and ecosystem health Matthew Fisher Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Year in infectious disease - Top ten papers Bart Jan Kullberg ECCMID 27th (2017) Vienna , Austria
Fungal infections in patients with hematological malignancies: advances in diagnosis and prevention Y. Kanda ISHAM Tokyo May 25-29 2009
Alkaptonuria and Aspergillus nidulans M. Penalva General
Antifungal Drug Development Summit (2015) Playlist All Antifungal Drug Development Summit
Top Papers on Invasive Fungal Disease Management 2014-15 Souha S. Kanj, MD, FACP, FIDSA ECCMID 25th (2015) Copenhagen Denmark
A bird's eye view of the fungal kingdom- changing species names (2) Sybren de Hoog Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Treatment of invasive aspergillosis: Polyenes, azoles, echinocandins? T. Patterson Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Canine sino-aspergillosis parallels with human disease M. Day Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Impact of prophylaxis on galactomannan, ß-D-glucan and PCR JP. Donnelly Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Clinical relevance of resistance in Aspergillus DW. Denning ICAAC 47th Chicago September 17-20th 2007
Transcriptomic regulatory analysis of the dendritic cell response to post-lung transplant invasive aspergillosis Amit Adlakha ECCMID 27th (2017) Vienna , Austria
Surgical infection and outbreaks M. Richardson Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Risk assessment in the Haemato-Oncologic patient Martin Hoenigl Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
The impact of environmental fungi on housing and building design M. Chapman Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Comparison of the two sequenced clinical isolates of A. fumigatus N. Fedorova Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Is pre-emptive therapy a realistic approach? JP. Donnelly ECCMID 21st / 27th ICC (2011) Milan, Italy
Regulatory aspects of aspergillus nomenclature P. Dijck Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Optimal antifungal prophylaxis - the case for posaconazole O. Cornely Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Quantitative PCR in Microbial Assessment of Indoor Spaces Martin Täubel Indoor Air 2015
Accuracy of PanFungal PCR sequencing for diagnosis of invasive fungal disease directly from clinical samples Carlos Gomez ECCMID 27th (2017) Vienna , Austria
Burden and distinctive character of ABPA in India R. Agarwal Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Oxygen and Invasive Aspergillosis Robert Cramer ICAAC 2014, Washington Sep 5-9
Current recommendations for the prevention of nosocomial infection: are they applicable to moulds? R. Barnes ECCMID 16th (2006) Nice, France
Neutrophils and damage during invasive aspergillosis: Superoxide and STAT3 S. Holland Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Immune regulation in idiopathic bronchiectasis R. Boyton Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Biofilm formation by Aspergillus G. Ramage Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Azole resistance in Aspergillus - clinical impact in haematological patients Dieter Buchheidt ECCMID 27th (2017) Vienna , Austria
Clinical risk factors for invasive aspergillosis J. Baddley Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Factors influencing the outcome of therapeutic penetrating keratoplasty for mycotic & supparative keratitis Thomas et al ISHAM 2015
Update on Job's (Hyper IgE) Syndrome: the many paths of STAT3 A Freeman ICAAC, 53rd, Denver September 10-13 2013
Getting to the diagnosis of aspergillosis-tests and their interpretation DW. Denning Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Introduction to workshop Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Early diagnosis and pre-emptive therapy of fungal pneumonia in high risk patients: Current thinking K. Marr ICAAC 2006 Sept 27-30, San Francisco
Indoor fungi and climate change R. Samson Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Fungal rhinosinusitis - a categorization and definitional schema DW. Denning ISHAM Tokyo May 25-29 2009
The changing epidemiology of invasive aspergillosis W Meersseman Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Discovery of novel antifungal drug targets Yong-Sun Bahn PhD Antifungal Drug Development Summit
Aspergillus PCR achieving standardisation Peter Donnelly ISHAM 2015